AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Siris Medical Announces Release of PlanMDTM Software, a New AI Decision Support Solution for Radiation Oncology

October 19, 2018 GMT

SAN FRANCISCO--(BUSINESS WIRE)--Oct 19, 2018--Siris Medical, Inc., headquartered in Silicon Valley and Boston, offers the only Artificial Intelligence (AI) treatment decision-support system for use in radiation oncology. The new PlanMD TM software enables radiation oncology clinical teams to leverage patient data and artificial intelligence to efficiently empower their treatment decisions. The PlanMD TM software is the first and only tool that enables the physician to see the effect of editing contours in real-time, without re-optimizing or replanning. PlanMD TM complements Siris Medical’s QuickMatch TM software, which accelerates the treatment planning process by using artificial intelligence to quickly identify the most similar cases previously treated to inform planning decisions and help reduce dose to critical structures.

“Radiation treatment planning is complex, highly iterative and involves many clinical team members. Through the use of Artificial Intelligence to support decision making, our software has been shown to enable clinical teams to save up to 70% of the time required to plan treatment, while also improving the quality of treatment being delivered,” said Colin Carpenter PhD, President and CEO of Siris Medical.

This announcement follows a recent publication, “Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making,” in the Journal of Radiotherapy and Oncology in December 2017. This study demonstrates the unique ability of the QuickMatch TM software to draw upon historical clinical insights for patient-specific decision making. The study was a collaborative effort between UCSF, University of Pennsylvania, University of Maryland, and Siris Medical.

Marc Nash MD, Chief Medical Officer at Siris Medical said, “The decision support capabilities of PlanMD TM have the potential to benefit clinical teams and patients by making the radiation therapy treatment planning process faster and its workflows smarter, resulting in better treatment plans with the ultimate goal of achieving better outcomes. This software is exactly what I was looking for during my time in the clinic to help me make treatment decisions with confidence; it would have saved me hours.”

About Siris Medical

Siris Medical empowers clinicians to efficiently make high-quality radiation treatment decisions through its proprietary artificial intelligence platform. Please visit www.siris-medical.com for more information. The PlanMD TM software is a module of the Siris Medical InsightRT TM software suite, which has been cleared by the US FDA.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181019005384/en/

CONTACT: Siris Medical, Inc

Colin Carpenter, 650-394-5161

President and CEO

carpenter@siris-medical.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA MASSACHUSETTS

INDUSTRY KEYWORD: TECHNOLOGY SOFTWARE HEALTH MEDICAL DEVICES ONCOLOGY

SOURCE: Siris Medical, Inc.

Copyright Business Wire 2018.

PUB: 10/19/2018 09:16 AM/DISC: 10/19/2018 09:16 AM

http://www.businesswire.com/news/home/20181019005384/en